Autism Spectrum Disorder Trial, Recruiting (NCT07551752)

Autism Spectrum Disorder Trial, Recruiting NCT07551752 Sponsor: Florida International University Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT07551752 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the child:

The child is between 14 and 48 months old
The child either scored positively on a standard early autism screening tool (called the M-CHAT-R/F) or has already been diagnosed with autism

For the parent or caregiver:

The parent or caregiver is at least 18 years old
The parent or caregiver is fluent in English
The parent or caregiver is willing to attend both study visits and, if placed in the intervention group, review the OPT-In-Early program
The parent or caregiver has access to a device that connects to the internet

Who may not be able to join:

Children who have a neurological condition that would prevent them from participating in the intervention or completing the study assessments (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 305-348-1034

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07551752

Sponsor: Florida International University

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 305-348-1034

More information: https://clinicaltrials.gov/study/NCT07551752

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For the child:

The child is between 14 and 48 months old
The child either scored positively on a standard early autism screening tool (called the M-CHAT-R/F) or has already been diagnosed with autism

For the parent or caregiver:

The parent or caregiver is at least 18 years old
The parent or caregiver is fluent in English
The parent or caregiver is willing to attend both study visits and, if placed in the intervention group, review the OPT-In-Early program
The parent or caregiver has access to a device that connects to the internet

Who may not be able to join:

Children who have a neurological condition that would prevent them from participating in the intervention or completing the study assessments (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Florida International University

Registry

ClinicalTrials.gov

Start date

11 April 2026

Est. completion

1 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Motor Imitation Scale; Vineland Scales of Adaptive Behavior-3; MacArthur-Bates Communicative Development Inventories (MCDI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov